Form 4: Progyny CEO Sells Shares to Cover Tax Obligations

Progyny's CEO, Peter Anevski, sold 6,162 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Peter Anevski, the CEO of Progyny, Inc., sold 6,162 shares of common stock on January 2, 2025.
• The sale was executed at a price of $17.25 per share.
• This transaction was to cover withholding taxes due upon the vesting of restricted stock units.
• Following the transaction, Anevski directly owns 435,301 shares of Progyny common stock.
• Anevski also indirectly owns an unspecified amount of shares through PECO ANEVSKI 2020 SD LLC.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes and does not indicate any positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax liabilities when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The sale of 6,162 shares is relatively small compared to the total holdings of the CEO and is not unusual for this type of transaction.
• Other companies such as Teladoc Health (TDOC) and Livongo (LVGO) have seen similar transactions by their executives.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders as it is a routine sale for tax purposes.

Key Dates

Keywords

Progyny, CEO, Peter Anevski, stock sale, Form 4, insider trading, restricted stock units, tax obligations